Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02360033
Other study ID # SOPHO-PT-2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2015
Est. completion date September 2017

Study information

Verified date October 2019
Source Heidelberg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Goals of the study:

Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but lack explicit details about the clinical significance of the reductions they show in social anxiety symptoms. This project is funded by the German Association for Systemic Therapy, Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und Familientherapie: DGSF).

Study design:

The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders (SAD) in 32 patients.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date September 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Social Anxiety Disorder (SKID: ICD-Diagnosis: F40.1, Liebowitz Social Anxiety Scale > 30);

- Agreement to participate in the study and to be randomized into the two treatment groups

Exclusion Criteria:

- Acute drug or alcohol intoxication or dependency

- Anorexia with BMI < 14

- Psychotic disorder

- Severe physical diseases

Study Design


Intervention

Behavioral:
Systemic Therapy for Social Anxiety Disorder

Cognitive Behavioral Therapy for Social Anxiety Disorder


Locations

Country Name City State
Germany Institute of Medical Psychology, University Hospital Heidelberg Heidelberg Baden-Württemberg

Sponsors (4)

Lead Sponsor Collaborator
Heidelberg University German Association for Systemic Therapy, Counseling and Family Therapy (DGSF), Heidehof Foundation, Systemic Society (SG)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Liebowitz Social Anxiety Scale (LSAS-SR) Social Anxiety will be assessed using the Liebowitz Social Anxiety Scale (LSAS-SR) in its German version. The LSAS-SR is a brief 24-item self report instrument with 13 items relating to performance anxiety and 11 concerning social situations. Its purpose is to assess the range of social interaction and performance situations feared and the degree of avoidance by a patient in order to assist in the diagnosis of social anxiety disorder, 24 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Primary Change of Social Interaction Anxiety Scale (SIAS) Measure of social interaction anxiety, 20 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Primary Change of Social Phobia Scale (SPS) Measure of anxiety while being observed by others, 20 items, German version Baseline, 8th,15th and 20th hour of therapy, end of treatment; 6, 9 and 12 months after randomization
Secondary Change of Adjustment to Symptomatology Scale (ASS) Measure of adjustment to the symptomatology, 5 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Evaluation of Social Systems (EVOS) Measure of social relationships in different social systems, 10 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Experience in Social Systems (EXIS) Measure of the individual experience in different social systems, 24 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Beck Depression Inventory-II (BDI-II) Severity of depressive symptoms "at that moment", specifically assessing the intensity of depression in psychiatric and normal populations, 21 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Brief Symptom Checklist (BSCL) The instrument provides an overview of a patient's symptoms and their intensity at a specific point in time, 53 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Inventory of Interpersonal Problems (IIP-32) The IIP-32 is a self-report instrument that identifies a person's most salient interpersonal difficulties. It is a short version of the Inventory of Interpersonal Problems, 32 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Dyadic Adjustment Scale (DAS-12) Measure of relationship adjustment, 12 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of University of Rhode Island Change Assessment (URICA-S, short version) Measure of stages of change, 16 items, German version Baseline, 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
Secondary Change of Burden Assessment Scale (BAS) Measure of perceived burden in daily life among resource persons, 19 items, German version Baseline, 26th hour of therapy; 12 months after randomization
Secondary Change of Scale for the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (SACiP), Measure of the six dimensions of resource activation, problem actuation, mastery, clarification of meaning, emotional bond, agreement on collaboration, 21 items, German version 8th,15th, 20th and 26th hour of therapy; 6, 9 and 12 months after randomization
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06274112 - Using TMS to Understand Neural Processes of Social Motivation N/A
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00684541 - Interpretation Modification Program for Social Phobia N/A
Completed NCT00684320 - Attention Disengagement Training for Social Phobia N/A
Completed NCT03247075 - Internet-delivered CBT vs Internet-delivered Support and Counseling for Youth With Social Anxiety Disorder - An RCT N/A
Completed NCT02811458 - Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders N/A
Withdrawn NCT04622930 - Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD) N/A
Active, not recruiting NCT05018312 - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety N/A
Active, not recruiting NCT05124639 - Clinical Trial of a Group Self-management Support Program for Anxiety Disorders N/A
Completed NCT05858294 - The Safety, Acceptability and Efficacy of Alena N/A
Active, not recruiting NCT05600114 - Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder Phase 2
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Not yet recruiting NCT02924610 - Brief Intervention to Reduce Fear Phase 4
Active, not recruiting NCT02592564 - Brain Plasticity and Cellular Aging After Internet-delivered CBT for Social Anxiety Disorder N/A
Recruiting NCT02305537 - Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment N/A
Terminated NCT03764644 - Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders N/A
Unknown status NCT01712321 - Study of Vilazodone to Treat Social Anxiety Disorder N/A
Completed NCT01320800 - CBT for Social Anxiety Disorder Delivered by School Counselors Phase 2
Completed NCT00485615 - An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia Phase 2
Completed NCT00773162 - Flushing in Social Anxiety Disorder on Seroquel Phase 3

External Links